Brain Monitoring Global Market Report 2024

Brain monitoring involves the continuous online measurement of cerebral blood flow and volume waves, providing valuable data for individualized patient management in brain and neuro-related diagnostics and treatments.

The main product types in brain monitoring include magnetoencephalography, electroencephalography, cerebral oximeters, functional magnetic resonance imaging (fMRI), intracranial pressure monitoring devices, and other related technologies. Magnetoencephalography is a noninvasive technique that detects and records the magnetic field associated with electrical activity in the brain. Procedures can be both invasive and non-invasive, with applications spanning conditions such as Parkinson’s disease, traumatic brain injury, epilepsy, dementia, sleep disorders, and more. The end-users of brain monitoring technologies include hospitals and clinics, neurology centers, ambulatory surgery centers, diagnostic centers, and other healthcare facilities.

The brain monitoring market research report is one of a series of new reports that provides brain monitoring market statistics, including brain monitoring industry global market size, regional shares, competitors with a brain monitoring market share, detailed brain monitoring market segments, market trends and opportunities, and any further data you may need to thrive in the brain monitoring industry. This brain monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The brain monitoring market size has grown rapidly in recent years. It will grow from $7.49 billion in 2023 to $8.26 billion in 2024 at a compound annual growth rate (CAGR) of 10.2%. The growth observed during the historical period can be attributed to several factors, including the increased prevalence of neurological disorders, a demand for real-time brain monitoring in surgical and critical care settings, growth in research on brain-computer interfaces (BCIs) and neurofeedback, expansion of the aging population, and increased adoption of brain monitoring for sports optimization.

The brain monitoring market size is expected to see strong growth in the next few years. It will grow to $12.07 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The anticipated growth in the forecast period can be attributed to the development of more affordable and accessible brain monitoring devices, increased application of brain monitoring in mental health and psychiatric care, expansion of neurocritical care units and stroke centers in healthcare facilities, regulatory support for the approval and use of brain monitoring technologies, and the growing importance of pediatric neurology and neonatal brain monitoring. Noteworthy trends expected during this period include advancements in neuroinformatics and data integration, the utilization of neurofeedback and brain training, integration of brain-computer interfaces (BCIs), the use of blockchain for data security, and the application of brain monitoring in space exploration.

The growth of the brain monitoring market is expected to be propelled by the increasing incidence and prevalence of neurological disorders. Brain monitoring involves the use of instrumentation to assess neurologic injuries, providing enhanced accuracy and reliability in evaluating the severity of such injuries. According to a report from the World Health Organization (WHO), the global occurrence of neurological health problems is projected to reach nearly 103 million by 2030. Consequently, the rising demand driven by the increasing incidence and prevalence of neurological disorders is a key factor driving the growth of the brain monitoring market.

Government initiatives supporting next-generation invasive devices are anticipated to further contribute to the expansion of the brain monitoring market. These initiatives involve specific actions, programs, policies, or projects undertaken by government authorities at various levels to address issues, achieve goals, or create positive changes in healthcare. For instance, in 2023, the National Institutes of Health (NIH), a U.S.-based government agency, issued a funding opportunity announcement (FOA) encouraging investigators to pursue first-in-human or early-stage clinical studies for next-generation invasive devices. Government initiatives aimed at advancing next-generation invasive devices play a crucial role in driving growth within the brain monitoring market.

Collaborations among major companies in the brain monitoring market to develop advanced solutions, such as at-home brain monitoring and machine learning-enabled neurodiagnostics, are expected to boost market revenues. Strategic partnerships offer various advantages, including increased access to expertise and resources, accelerated innovation, and improved patient care. In May 2022, Beacon Biosignals, a U.S.-based neuro-biomarker platform, entered into a partnership with Stratus, a U.S.-based technology company. This collaboration aims to enhance at-home brain monitoring and machine learning-enabled neurodiagnostics by leveraging Beacon's machine-learning neuroanalytics platform and Stratus's expertise in providing electroencephalogram (EEG) services. Such collaborations reflect a commitment to advancing brain monitoring technologies and expanding their applications.

The brain monitoring market is witnessing major companies developing innovative systems to gain a competitive edge. Neurosteer, an Israel-based medical company, introduced its Neurosteer EEG brain monitoring platform in November 2022. This single-channel electroencephalogram (EEG) system, approved by the Food and Drug Administration (FDA), provides technical status indicators about the recording, including battery level, connection status, and electrode impedance. The platform is designed to facilitate quick and cost-effective mass screening of participants in clinical trials for neurodegenerative disorders. This innovation reflects the company's commitment to advancing brain monitoring technologies for clinical applications.

In October 2021, Brain Scientific Inc., a neurology-focused medical device and software company based in Florida, merged with Piezo Motion Corp. This strategic merger not only expanded the company's market reach but also increased its capacity to launch disruptive products. Piezo Motion Corp., based in Florida, is known for its innovations in high-precision motion technology. The merger underscores the trend of companies seeking strategic collaborations and mergers to enhance their capabilities and bring innovative solutions to the market.

Major companies operating in the brain monitoring market include Natus Medical Inc., Nihon Kohden Corporation, Philips Healthcare NV, GE Healthcare Technologies Inc., Compumedics Ltd., Medtronic PLC, Edwards Lifesciences Corporation, Advanced Brain Monitoring, Masimo Corporation, Spiegelberg GmbH & Co. KG, Cadwell Industries Inc., Elekta A.B, Drägerwerk AG & Co. KGaA, Electrical Geodesics Inc., Integra LifeSciences Corporation, Siemens AG, CAS Medical Systems Inc., Neural Analytics Inc., BrainScope Company Inc., NeuroWave Systems Inc., Neurosoft Company, NeuroSky Inc., NeuroVigil Inc., OpenBCI Inc., Qneuro Pvt. Ltd., Soterix Medical Inc., Wearable Sensing Inc., Brain Products GmbH, Brain Vision LLC, ANT Neuro B.V., Blackrock Microsystems LLC, Cognionics Inc., Emotiv Inc., G.TEC Medical Engineering GmbH, MindMaze SA

North America was the largest region in the brain monitoring market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain monitoring market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the brain monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The brain monitoring market includes revenue earned by entities by functional magnetic resonance imaging (FMRI), magnetoencephalography (MEG) and electroencephalography (EEG).The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.